Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6282017 | 0.92 | TYR (0.51) | SLC5A2TYRPOLBACHE | |
| SCHEMBL6282545 | 0.90 | EPHX2 (0.36) | SLC5A2POLBEPHX2 | |
| SCHEMBL12500750 | 0.85 | TYR (0.46) | SLC5A2TYRPOLBACHE | |
| SCHEMBL10305226 | 0.85 | TYR (0.46) | SLC5A2TYRPOLBACHE | |
| SCHEMBL10180096 | 0.85 | TYR (0.46) | SLC5A2TYRPOLBACHE | |
| SCHEMBL10179591 | 0.83 | CA1 (0.43) | SLC5A2TYRACHE | |
| SCHEMBL10305206 | 0.83 | CA1 (0.43) | SLC5A2TYRACHE | |
| SCHEMBL6282040 | 0.81 | SLC5A2 (0.48) | SLC5A2TYRPOLBEPHX2 | |
| SCHEMBL24419020 | 0.79 | GAA (0.50) | ACHE | |
| SCHEMBL21334204 | 0.77 | TYR (0.64) | SLC5A2TYRPOLBEPHX2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958395-B2 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by Diels-Alder reaction | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2005-10-25 | — | — | US | disclosed |
| US-20040059101-A1 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by diels-alder reaction | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2004-03-25 | — | — | US | disclosed |
| EP-1313750-A1 | METHOD FOR PRODUCING WATER-SOLUBLE SACCHARIDE CONJUGATES AND SACCHARIDE MIMETICS BY DIELS-ALDER REACTION | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2003-05-28 | — | — | EP | disclosed |
| WO-2002016378-A1 | METHOD FOR PRODUCING WATER-SOLUBLE SACCHARIDE CONJUGATES AND SACCHARIDE MIMETICS BY DIELS-ALDER REACTION | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2002-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040059101-A1 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by diels-alder reaction | SI, MAN1B1, SORD | SLC5A2 197/4885TYR 2837/4885POLB 3073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.